![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiGCPHYZw85cBtMwHaQ6YFUzjPHuzJCxqgvN6OcBXlYHPbD9RlQpHqQNhXEYiRhnvM3iUKJ4Co88PAqR3RHhxzTfD1rLF0yRYBI3INvz4izU_1Qx1qhGfkHT52kwCRzQSECwOZr8RWFQSc/s200/917269___pills__.jpg)
Daniel Grima from Cornerstone Research in Canada brought this news link to my attention. According to the numbers presented in the article, we are in for a very bumpy ride. The Wall Street Journal estimated that generics will be taken out $67 billion annual U.S. sales from the top pharmaceutical companies over the time frame 2007 to 2012. The alarming piece of news is that these $67 billion represent 50% of the total U.S. sales of those companies.
No comments:
Post a Comment